ICD-10-CM Billable Code

Q17.2

Microtia

Clinical Classification Guidelines

Medical Intelligence & Overview

Microtia is a congenital condition characterized by an abnormally small or underdeveloped external ear. This condition can affect one or both ears and varies in severity, influencing the appearance and, in some cases, the hearing ability of affected individuals. Typically noticeable at birth, microtia may occur as an isolated anomaly or as part of a syndrome involving other congenital abnormalities. Early awareness and assessment are important for management and potential corrective options.

Causes & Symptoms

Clinical Causes: The precise cause of microtia remains unknown in many cases; however, it is believed to result from disruptions during the development of the ear in the early fetal stages. Factors that may contribute include: - Genetic factors: Family history or inherited traits - Environmental influences: Exposure to teratogens such as certain drugs, alcohol, or toxins during pregnancy - Developmental issues: Disruption in the blood supply or cell formation in the first trimester - Associated syndromes: Microtia often occurs as part of syndromes such as Treacher Collins syndrome or Hemifacial Microsomia Understanding these causes can help in early diagnosis and planning for treatment options.

Key Symptoms: The main features and symptoms associated with microtia include: - Underdeveloped external ear, which may appear as a small, malformed, or absent pinna - Abnormal ear shape or size - Possible absence of ear structures such as the external auditory canal - Hearing loss, especially if the middle or inner ear structures are affected - Asymmetry between the ears if only one ear is affected - For some individuals, additional facial malformations or syndromic features These symptoms might vary widely depending on the severity and associated conditions, prompting different levels of intervention.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of microtia typically occurs at or shortly after birth through physical examination. To confirm the extent of the condition and assess associated abnormalities, healthcare providers may recommend: - Imaging studies such as CT scans or MRIs to evaluate the ear's internal structures - Hearing tests like audiometry to determine the degree of hearing impairment - Genetic testing if microtia is suspected to be part of a syndrome - Thorough assessment for other facial or cranial anomalies Early diagnosis is crucial for planning appropriate management strategies and addressing potential hearing or cosmetic concerns.

Treatment Protocols: Management of microtia often involves a multidisciplinary approach tailored to the individual's needs. Common options include: - Surgical reconstruction: Procedures such as tympanoplasty or ear reconstruction using cartilage or synthetic materials to improve appearance and, sometimes, hearing - Hearing rehabilitation: Use of hearing aids or bone-anchored hearing systems if hearing loss is present - Speech therapy and educational support: To address communication difficulties resulting from hearing impairment - Regular monitoring: Continuous assessment of ear development, hearing, and potential associated syndromic features - Psychological support: Counseling services to help with social and emotional well-being Advances in surgical techniques and hearing devices continue to improve outcomes for individuals with microtia, emphasizing early intervention and personalized care.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q17.2 a billable ICD-10 code?
Yes, Q17.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q17.2?
Clinical documentation must specify the nature of Microtia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

microtia